| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |